Research on HIV/AIDS Drug Resistance Testing
- Understanding HIV-Related Lab Tests II: Viral Load, Resistance and Tropism (June 2012)
From The Well Project
- Free Online Resource for Treatment Decisions Without Access to Genotype Resistance Tests (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Genotypic Test Matches Tropism Test in Predicting Who Benefits From CCR5 Inhibitors (July 28, 2009)
A genotypic test is just as accurate as a more expensive tropism test in determining which treatment-experienced patients are suitable for treatment with the CCR5 inhibitor maraviroc, researchers from the University of British Columbia reported.
From aidsmap.com
- Genetic Test Predicts Response to Maraviroc in Treatment-Experienced HIV Patients (July 22, 2009)
To read PDF, click here.
From British Columbia Centre for Excellence in HIV/AIDS
- Abacavir Hypersensitivity Test Could Be Combined With Drug Resistance Test: Study (June 4, 2007)
From aidsmap.com
- HIV Test May Show Which Drugs Work Best (January 8, 2007)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- Resistance Testing Can Level the Playing Field for People Starting Treatment, Study Says (May 4, 2006)
From aidsmap.com
- More Sensitive Drug-Resistance Tests Yield Higher Rates of Multidrug Resistance in Treatment-Naive Patients (February 8, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections On TheBodyPRO.com
- Researchers Examine Use of Artificial Intelligence to Select Ideal Regimens for Treatment-Experienced Patients (December 17, 2005)
In The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy On TheBodyPRO.com
- Small Study Suggests Genotypic Resistance Tests Maintain Accuracy Even When Viral Load Is Below 1,000 (December 17, 2005)
In The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy On TheBodyPRO.com
VIEW ALL ARTICLES
|
Advertisement
|